Skip to the page

Data / Drug companies / Insulin

Insulin drugs: 2 drugs from 8 companies in the FDA NDC directory

Insulin is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 30 products in this class from 8 companies, covering 2 drugs by generic name. The main marketing category is biologics (BLA), and the newest product started marketing on July 24, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 8Companies
  • 30Products
  • 2Drugs by generic name

Drugs in the Insulin class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Insulin human124
Human insulin72

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Eli Lilly and Company7injection, suspension; injection, solutionBiologics (BLA)December 29, 2015
Novo Nordisk6injection, suspension; injection, solutionBiologics (BLA)September 6, 2019
Deseret Biologicals, Inc.5liquid; tabletUnapproved homeopathic productsJuly 24, 2026
Nutritional Specialties, Inc.4spray; liquidUnapproved homeopathic productsApril 2, 2026
Mannkind Corporation3powder, meteredBiologics (BLA)July 1, 2017
A-S Medication Solutions2injection, solution; injection, suspensionBiologics (BLA)June 25, 1991
Energique, Inc.2liquidUnapproved homeopathic productsJune 25, 2026
Baxter Healthcare Corporation1injection, solutionBiologics (BLA)July 12, 2019

Dosage forms

Dosage formProductsShare
Injection, suspension930%
Injection, solution723.3%
Liquid723.3%
Powder, metered310%
Spray310%
Tablet13.3%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.